Structural selectivity of human SGLT inhibitors

Human Na(+)-d-glucose cotransporter (hSGLT) inhibitors constitute the newest class of diabetes drugs, blocking up to 50% of renal glucose reabsorption in vivo. These drugs have potential for widespread use in the diabetes epidemic, but how they work at a molecular level is poorly understood. Here, w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hummel, Charles S., Lu, Chuan, Liu, Jie, Ghezzi, Chiari, Hirayama, Bruce A., Loo, Donald D. F., Kepe, Vladimir, Barrio, Jorge R., Wright, Ernest M.
Format: Artigo
Langue:Inglês
Publié: American Physiological Society 2012
Sujets:
Membrane Transporters, Ion Channels and Pumps
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3328840/
https://ncbi.nlm.nih.gov/pubmed/21940664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpcell.00328.2011
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires